Crosslink Therapeutics

Boston, MA · Founded 2022 · Privately Held (backing)

Operator of a biologics platform intended to enable targeted cancer treatment using tumor-specific biochemical markers. Crosslink Therapeutics is based in Boston, MA and was founded in 2022. It has raised $8 million across 1 recorded round; the latest was a $4.3 million seed round in Apr 2025.

Last price · $/share
—
Implied valuation
—
Total raised
$8.0M
Last round
Seed Round
Apr 2025
Cap table — not yet on record

Crosslink Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Crosslink Therapeutics with a free account
  • ·Watch Crosslink Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Crosslink Therapeutics

Where does Crosslink Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Crosslink Therapeutics's 1 recorded funding rounds.